Taking Pain Relief Products to Market. Since 2012.

Partner with us See our products

Start here

5 ways to work with Terrain Rx.

Not sure? Talk to us

Pharmaceutical companies

Rapid U.S. entry, channel expansion, lifecycle extension, and liquidity for dormant ANDAs.

CMOs & CDMOs

Capital-backed scale-up, tech-transfer expertise, guaranteed off-take, and FDA gap-filling for foreign manufacturers.

Specialty wholesalers

Differentiated SKUs, predictable lead times, and collaborative marketing support.

Independent pharmacies

Stable reimbursement, special-order speed, and co-branded patient education, through your usual wholesaler.

Patients & providers

Comfort-first formulations that lower systemic side effects and fit daily life.

Who we are

Innovative Therapies,
Powered by Proven Distribution

Founded in 2012 and headquartered in Reno, Nevada, Terrain Pharmaceuticals Inc. is a leading commercialization and launch partner for pain relief products in the U.S.

  • Regulatory strategy across ANDA, 505(b)(2), and OTC pathways, with change-control governance.
  • Pricing, chargeback, and compendia setup staged alongside the filing.
  • Flexible deal structures: licensing, co-promotion, co-development, and asset acquisition.
  • Commercial operations, reimbursement, channel management, and distribution analytics from one accountable partner.
More about Terrain Rx
Pharmaceutical distribution shelving stocked with bottles and cartons

Capabilities

14 years of built infrastructure.

Coverage
50states, via specialty wholesalers, independent pharmacies, and dispensing-physician networks
Practice network
3,000+clinics reached through the physician-services channel
Approval to revenue
5–10months from late-stage clearance to active U.S. sale
Slated through Q1 2027
9launches across topical and oral pain, gastroenterology, and neurology

Our products

Non-addictive pain relief and supportive care.

Prolaxa® Docusate Sodium Softgel

OTC250 mg100 softgels

NDC 53225-2001-1

Meloxicam Tablets, USP · 7.5 mg · 30 ct

Rx7.5 mg30 ct

NDC 53225-3075-1

Meloxicam Tablets, USP · 7.5 mg · 60 ct

Rx7.5 mg60 ct

NDC 53225-3075-2

Meloxicam Tablets, USP · 7.5 mg · 500 ct

Rx7.5 mg500 ct

NDC 53225-3075-6

Meloxicam Tablets, USP · 15 mg · 30 ct

Rx15 mg30 ct

NDC 53225-3015-1

Meloxicam Tablets, USP · 15 mg · 500 ct

Rx15 mg500 ct

NDC 53225-3015-6

Lidocaine Patch

OTC4%30 patches

NDC 85096-201-30

Menthol Patch

OTC5%30 patches

NDC 85096-301-30

Capsaicin Patch

OTC0.025%30 patches

NDC 85096-401-30

Methyl Salicylate 25% Cream

OTC25%120 g tube

NDC 85096-001-42

Pipeline

9 launches slated through Q1 2027.

Q3 2026

  • Lidocaine patch (PHN)
  • Anticonvulsant capsules

Q4 2026

  • SNRI capsules
  • Antibiotic tablets
  • NSAID capsules
  • PPI capsules

Q1 2027

  • LidoPro® Patch XR
  • NSAID solution
  • Lidocaine 5% ointment

See the full pipeline

Contact

Talk to a person.

877 985 8377

info@terrainrx.com

  • Address
    3650 Mayberry Dr, Suite 101-2
    Reno, NV 89509
  • Hours
    Mon–Fri, 8:00 AM – 5:00 PM Pacific
    Closed weekends and major U.S. holidays
  • Quality

Safety

Medical emergencies. Our products are not intended for emergency treatment. Call 911 or visit your nearest emergency room.

Adverse event reporting. Contact our Quality Department at qa@terrainrx.com, or report to FDA MedWatch at (800) FDA-1088.

Inquiry form

Send an inquiry.

The form opens by asking which of our audiences you belong to, then routes what you send to the representative who handles it.

  • Who you are, and your reason for writing
  • Name, company, and contact details
  • Your message

By providing your mobile number, you agree Terrain Pharmaceuticals Inc may text you for operational follow-up on this inquiry (not marketing). Message frequency varies. Msg & data rates may apply. Reply STOP to opt out, HELP for help. Consent not required to submit.
Privacy  ·  Terms